Salivary Nitrite in Patients with Type 2 Diabetes Mellitus: Role of Diabetic Pharmacotherapy

Hayder M Alkuraishy, Ali I Al-Gareeb, Marta C Monteiro, Salah A Al-windy and Huda Jaber
Additional contact information
Ali I Al-Gareeb: Department of Pharmacology, Toxicology and Medicine College of Medicine Almustansiriya University, Iraq
Marta C Monteiro: Department of Pharmaceutical Science Post-Graduation Program, Neuroscience and Cell Biology Post-graduate Program Health Science Institute, Iraq
Salah A Al-windy: Department of Biology and Biochemistry, College of Sciences Baghdad University, Iraq
Huda Jaber: Department of biochemistry, College of Pharmacy, Iraq

Global Journal of Pharmacy & Pharmaceutical Sciences, 2017, vol. 1, issue 2, 39-43

Abstract: Salivary nitrite is derived from salivary nitrate that obtained from ingested nitrate since 25% of nitrate is secreted through saliva thus; salivary nitrate is 10-20 times higher than plasma nitrate. Nitrate-nitric-NO pathway plays a role in prevention of insulin resistance and progression of diabetes mellitus. Because of salivary nitrite is also generated from NO metabolism therefore, salivary nitrite may reflect the endogenous NO production and endothelial function in various diseases thus; the aim of present study was evaluation of salivary nitrite in controlled and complicated T2DM regarding the current diabetic pharmacotherapy. In this study a total number of 50 patients with T2DM were selected randomly compared with 27 healthy subjects. 10ml of venous blood from all patients and healthy subjects after an overnight fasting was drawn, lipid profile, fasting blood glucose, plasma nitrate, plasma nitrite, nitric oxide NO and salivary nitrite were determined in patients with T2DM regarding specific diabetic pharmacotherapy and complications compared to healthy control. Salivary nitrite was high in patient with complications p=0.04 compared with control and near normal in diabetic patient without complications. Metformin increases salivary nitrite more than glimepiride but combination of metformin plus glimepiride produced significant amelioration in salivary nitrite levels.

Keywords: juniper publishers:Journal of Pharmacy; Global Journal of Pharmacy; Pharmaceutical Sciences; Pharmacy & Pharmaceutical Sciences; pharmaceutical sciences journals; omics online; open access; drug discovery; Clinical Trials; juniper publishers open access journals; juniper publishers reivew (search for similar items in EconPapers)
Date: 2017
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/gjpps/pdf/GJPPS.MS.ID.555558.pdf (application/pdf)
https://juniperpublishers.com/gjpps/GJPPS.MS.ID.555558.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jgjpps:v:1:y:2017:i:2:p:39-43

DOI: 10.19080/GJPPS.2017.01.555558

Access Statistics for this article

Global Journal of Pharmacy & Pharmaceutical Sciences is currently edited by Sophia Mathis

More articles in Global Journal of Pharmacy & Pharmaceutical Sciences from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().